Molecular Technologist I-III at Tempus

Durham, North Carolina, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, BiotechnologyIndustries

Requirements

One of the following: MS in medical technology, clinical laboratory science, chemical, physical or biological science and 1 year pertinent clinical laboratory experience with molecular biology; OR BS/BA in medical technology, clinical laboratory science, chemical, physical or biological science and 1 year pertinent clinical lab experience in molecular biology
Excellent communication skills
Thrives in a fast-paced environment
Ability to work with others to plan and carry out scientific programs
Self-driven and works well in an interdisciplinary team with minimal direction
Strong desire to build products that will save lives and change the course of cancer
Impeccable attention to detail
Highly Desirable
Experience with next-generation sequencing
Work in a CLIA/CAP high-complexity laboratory
Experience with robotics and automated liquid handling systems
Knowledge of LIMS platforms and various computer systems

Responsibilities

Work with a cutting-edge genomics workflow to provide high-quality next-generation sequencing data with rapid turnaround times in a clinical laboratory
Perform routine testing, quality control, calibration, maintenance and proficiency testing in accordance with current laboratory procedures
Perform complex molecular-based procedures with a high degree of quality and in accordance with established protocols
Perform next-generation sequencing, including nucleic acid extraction, DNA/RNA quantification and qualification, NGS library preparation, probe hybridization, probe/library capture, library cleanup and quantification, loading sequencing libraries onto the Illumina Nextseq, HiSeq4000, and Novaseq
Sterilizing laboratory equipment and workspaces as assigned
Entering clinical patient data into the Laboratory Information Management system
Obtain 12 continuing education hours in the field of oncology or molecular biology
Maintain competency to perform all assigned molecular biology protocols in accordance with CAP, CLIA, NYSDOH regulations

Skills

Next-Generation Sequencing

NGS Library Preparation

Nucleic Acid Extraction

DNA/RNA Quantification

Probe Hybridization

Illumina NextSeq

HiSeq4000

NovaSeq

Quality Control

Laboratory Information Management System

Molecular Biology

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free